Stem Cells Cryopreservation Equipments Market Size, Share, Growth, and Industry Analysis, By Types (Liquid Phase, Vapor Phase), By Applications (Cord Blood Stem Cells Cryopreservation, Other Stem Cells Cryopreservation) , and Regional Insights and Forecast to 2035

Stem Cells Cryopreservation Equipments Market Size

The Global Stem Cells Cryopreservation Equipments Market size was valued at USD 101.3 Million in 2025 and is projected to reach USD 102.62 Million in 2026, USD 103.95 Million in 2027, and USD 115.27 Million by 2035, exhibiting a growth rate of 1.3% during the forecast period from 2026 to 2035. The market is driven by the increasing demand for stem cell-based therapies and the expanding stem cell banking industry. Over 40% of market growth is attributed to advancements in cryogenic storage systems and innovations in preservation techniques.

The US Stem Cells Cryopreservation Equipments Market is experiencing significant growth, accounting for a substantial share in the overall market. Approximately 38% of the market is driven by the increasing adoption of cryopreservation systems in biobanks and research facilities. Over 50% of clinical research organizations in the US have upgraded their cryogenic equipment to more efficient and automated systems, resulting in improved preservation efficiency and increased demand for advanced cryogenic solutions.

Key Findings

• Market Size: $101.3 Million (2025), $102.62 Million (2026), $115.27 Million (2035), 1.3% growth.
• Growth Drivers: Over 60% increase in regenerative medicine demand, 55% adoption of automated cryogenic systems.
• Trends: 58% rise in automation, 45% increased preference for vapor-phase cryopreservation systems.
• Key Players: Chart, Worthington Industries, Cesca Therapeutics, Shengjie Cryogenic Equipment, Sichuan Mountain Vertical.
• Regional Insights: North America holds 38% of the market share, driven by technological advancements and research infrastructure. Europe contributes 30%, with significant investments in regenerative medicine. Asia-Pacific accounts for 20%, fueled by growing healthcare and biobank demands. The Middle East & Africa represent 12% of the market share.
• Challenges: 43% of users face operational complexity, 35% report high maintenance costs impacting small institutions.
• Industry Impact: 62% of investments focused on automation, 45% directed toward improving storage capacities.
• Recent Developments: 58% of companies focused on product automation, 45% on enhancing cryogenic system reliability.

In the Stem Cells Cryopreservation Equipments Market, there is growing interest in automation, with more than 60% of research centers upgrading their cryogenic systems to improve operational efficiency. Additionally, the market is seeing a steady shift towards vapor-phase systems, accounting for 45% of new cryogenic equipment installations. With increasing research and advancements in regenerative medicine, the demand for efficient and safe stem cell storage solutions is projected to rise, fostering continuous innovations in cryogenic technologies. Adoption of more advanced systems in the US and Europe has also contributed to increased market share.

Stem Cells Cryopreservation Equipments Market Trends

The stem cells cryopreservation equipments market is witnessing strong momentum as demand for long-term stem cell storage grows across research institutes, biobanks, and regenerative medicine facilities. Over 58% of stem cell banking facilities have upgraded to advanced low-temperature preservation systems, indicating a clear shift toward higher operational precision. Additionally, more than 65% of laboratories now rely on automated cryogenic handling technologies to minimize contamination risks and improve specimen viability. The adoption of liquid nitrogen–based storage systems has risen by nearly 40% due to enhanced thermal stability and lower cellular degradation rates.

Market penetration of programmable freezers has increased by 32%, driven by the need for controlled cooling rates essential for stem cell integrity. Furthermore, the demand for vapor-phase storage solutions has expanded by 28% as users prioritize reduced cross-contamination exposure. With nearly 52% of stem cell research centers increasing their use of cryopreservation consumables, the market reflects robust scaling capacity. The stem cells cryopreservation equipments market continues to evolve with higher automation, better viability assurance, and increased safety features, fueling consistent technological adoption and diversification across applications.

Stem Cells Cryopreservation Equipments Market Dynamics

OPPORTUNITY

Expansion of Advanced Cryogenic Storage Infrastructure

Growing investment in stem cell preservation is creating a strong market opportunity as more than 62% of global biobanks are expanding their cryogenic storage capacity. Around 48% of research organizations have adopted next-generation freezing technologies to enhance cell viability and minimize contamination risks. Nearly 55% of regenerative medicine centers now rely on high-precision cryogenic systems, enabling scalability. This expanding infrastructure strengthens long-term demand for automated cryopreservation equipment across clinical and research applications.

DRIVERS

Growing Adoption of Regenerative Therapies

Increasing reliance on stem-cell–based therapies is driving accelerated equipment adoption. More than 67% of clinical research programs now require specialized cryopreservation tools to maintain stem cell potency during long-term storage. Additionally, about 51% of treatment development initiatives utilize automated freezing systems to ensure uniform cooling cycles. With programmable freezing technology seeing a 34% rise in adoption, regenerative medicine continues to reinforce market growth for highly efficient cryogenic equipment.

RESTRAINTS

"Operational Complexity and Higher Maintenance Requirements"

The market experiences notable restraints due to the complexity involved in operating advanced cryopreservation systems. Around 43% of laboratories report challenges managing the technical processes associated with cryogenic equipment. Nearly 39% of users highlight the need for additional staff training due to sophisticated interfaces and safety protocols. Additionally, 28% of facilities mention increased consumable usage rates, which intensify long-term operational burdens. These restraints often slow adoption among smaller institutions and resource-limited research units, resulting in uneven market penetration.

CHALLENGE

"Regulatory Compliance and Biosafety Barriers"

A major challenge within the industry stems from stringent regulatory frameworks governing cryogenic storage environments. Over 46% of stem cell storage facilities face difficulties meeting high biosafety standards required for proper cryopreservation operations. Approximately 33% of new installations are delayed due to infrastructure deficiencies identified during compliance checks. Furthermore, 29% of operators report problems navigating certification and validation procedures for high-grade equipment. These barriers extend setup timelines and elevate administrative workloads, posing persistent challenges for market acceleration.

Segmentation Analysis

The stem cells cryopreservation equipments market is segmented by type and application, with strong demand driven by technological innovation and expanding stem cell banking activities. The global stem cells cryopreservation equipments market size was USD 101.3 Million in 2025 and is projected to reach USD 102.62 Million in 2026 and USD 115.27 Million by 2035, exhibiting a CAGR of 1.3% during the forecast period. Each type and application segment demonstrates distinct growth patterns based on adoption rate, storage capacity demand, and performance efficiency across clinical and research environments.

By Type

Liquid Phase

Liquid phase cryopreservation equipment holds widespread adoption due to its capability to maintain stem cells at extremely low temperatures, ensuring high viability preservation. Nearly 54% of stem cell banks prefer liquid phase systems for superior thermal consistency. Over 47% report improved retention of cell morphology with this method, showcasing strong performance benefits across labs and research centers.

Liquid Phase Market Size, revenue in 2025 Share and CAGR for Liquid Phase. The segment contributed a significant portion of the total market in 2025, representing approximately 52% of global demand. This segment is projected to grow steadily at a CAGR of 1.3% through 2035 due to increasing reliance on stable cryogenic environments.

Vapor Phase

Vapor phase systems are gaining traction as they reduce direct contact with liquid nitrogen, decreasing contamination risks. Around 41% of laboratories now use vapor phase solutions, reflecting a growing preference for safer storage methods. Nearly 35% of clinical centers report enhanced specimen integrity with vapor-phase preservation.

Vapor Phase Market Size, revenue in 2025 Share and CAGR for Vapor Phase. Vapor phase systems accounted for roughly 48% of the total market share in 2025 and are expected to grow at a CAGR of 1.3% through 2035 due to expanding adoption in regulated environments.

By Application

Cord Blood Stem Cells Cryopreservation

Cord blood stem cells cryopreservation remains a dominant application due to increasing parental preference for long-term stem cell banking. More than 58% of cord blood storage facilities utilize advanced cryogenic equipment for optimized preservation. Additionally, 44% report improved post-thaw recovery rates, highlighting the effectiveness of technologically advanced systems.

Cord Blood Stem Cells Cryopreservation Market Size, revenue in 2025 Share and CAGR. This segment represented a significant share of the market in 2025, accounting for nearly 55% of total demand. It is projected to grow at a CAGR of 1.3% through 2035 driven by rising stem cell banking awareness.

Other Stem Cells Cryopreservation

Other stem cell cryopreservation applications, including mesenchymal and induced pluripotent stem cells, are expanding rapidly as research programs scale. Nearly 49% of advanced research centers depend on specialized cryogenic systems for these cell types. About 38% report increased usage of programmable freezers, showcasing rising technological integration.

Other Stem Cells Cryopreservation Market Size, revenue in 2025 Share and CAGR. This segment accounted for approximately 45% of the market in 2025 and is expected to grow at a CAGR of 1.3% through 2035 due to widening applications in regenerative science.

Stem Cells Cryopreservation Equipments Market Regional Outlook

The regional distribution of the stem cells cryopreservation equipments market shows significant variation in demand, influenced by healthcare infrastructure, research development, and adoption of regenerative medicine. North America, Europe, Asia-Pacific, and the Middle East & Africa collectively contribute to the growth of this market, with each region showcasing unique adoption trends and market shares. The global market size was USD 101.3 Million in 2025 and is projected to touch USD 102.62 Million in 2026, growing to USD 115.27 Million by 2035. North America, Europe, and Asia-Pacific each have a substantial market share, with North America holding the largest, followed by Europe, Asia-Pacific, and the Middle East & Africa.

North America

North America dominates the stem cells cryopreservation equipments market, accounting for approximately 38% of the global share. The region's market is bolstered by increasing investments in regenerative medicine, with 60% of research facilities expanding their cryopreservation capacities. Nearly 55% of stem cell research organizations in the U.S. have upgraded to advanced cryogenic systems, ensuring better preservation and cell viability. Strong government and private sector support for research in regenerative therapies further drives this demand. The North American market size in 2026 is projected to be USD 39.05 Million.

Europe

Europe holds the second-largest share in the stem cells cryopreservation equipments market, contributing around 30% of the global market share. The growing emphasis on stem cell-based therapies and biobanking in the European Union is expected to continue fuelling market demand. Over 50% of clinical research institutions in Europe have adopted automated cryogenic systems to enhance preservation reliability. Furthermore, the increase in stem cell banking activities in regions like Germany and the UK adds to the region's growth. The European market size in 2026 is estimated at USD 30.79 Million.

Asia-Pacific

Asia-Pacific is witnessing significant growth in the stem cells cryopreservation equipments market, accounting for approximately 20% of the global market share. This region is heavily investing in research infrastructure, with over 40% of new stem cell research initiatives utilizing cryogenic technologies. Countries like China, Japan, and India are actively expanding their stem cell storage capabilities to meet the rising demand for regenerative medicine. The Asia-Pacific market size in 2026 is projected to be USD 20.52 Million.

Middle East & Africa

The Middle East & Africa region holds about 12% of the global stem cells cryopreservation equipments market share. The demand for advanced cryogenic systems in this region is on the rise, primarily driven by growing interest in regenerative medicine and stem cell research. Approximately 38% of healthcare and research institutions in the region have begun adopting cryopreservation systems to support expanding biobanks and therapeutic research. In countries like the UAE and Saudi Arabia, investments in biotechnology are significantly enhancing the adoption of cryogenic technologies. The market size in 2026 for the Middle East & Africa is estimated to be USD 12.31 Million.

List of Key Stem Cells Cryopreservation Equipments Market Companies Profiled

Top Companies with Highest Market Share

• Chart: Leading with 25% market share.
• Worthington Industries: Holds 20% of the total market share.

Investment Analysis and Opportunities in Stem Cells Cryopreservation Equipments Market

Investment in the stem cells cryopreservation equipment market is increasingly focused on technological advancements, with around 58% of investments directed towards automation and system efficiency improvements. Moreover, over 45% of companies are focusing on expanding their geographic presence, particularly in emerging markets like Asia-Pacific, where demand for cryopreservation equipment is expected to grow rapidly. The opportunities are significant, with 32% of investments in the sector being funneled into research and development for new storage solutions. As global healthcare infrastructure continues to advance, 40% of the investments in stem cell cryopreservation technology are aimed at improving regulatory compliance, enhancing storage systems' compatibility, and reducing contamination risks.

New Products Development

The development of new products in the stem cells cryopreservation equipment market is becoming more focused on increasing efficiency and reliability. Approximately 55% of new product developments are centered around automating cryogenic systems to reduce human error and improve consistency. Nearly 37% of innovations focus on enhancing the storage capabilities for stem cells, particularly for those used in regenerative medicine, by incorporating better monitoring and control systems. Additionally, 32% of new products feature advancements in vapor-phase technology, which reduces contamination risks and improves cell viability. With the rise of personalized medicine, the development of more adaptable cryopreservation solutions to meet specific clinical needs is expected to account for 25% of new innovations.

Recent Developments

• Shengjie Cryogenic Equipment: In 2024, Shengjie launched a new liquid nitrogen-based cryopreservation system designed to improve cell viability by 30%. The system is equipped with advanced thermal sensors to ensure precise temperature regulation.
• Cesca Therapeutics: Cesca developed an automated cryopreservation system that reduces storage time by 15%, offering enhanced preservation capabilities for stem cell research centers.
• Worthington Industries: In 2024, Worthington Industries introduced an upgrade to its cryogenic freezers with improved energy efficiency, contributing to a 20% reduction in operational costs for large-scale biobanks.
• Qingdao Beol: Qingdao Beol launched a new line of cryopreservation consumables, improving the quality and longevity of stem cell storage by 25%, meeting the growing demands of global stem cell banks.
• Sichuan Mountain Vertical: Sichuan Mountain Vertical made advancements in vapor-phase cryopreservation technology, improving cryogenic storage efficiency by 18% with lower contamination rates in stored samples.

Report Coverage

The report on the stem cells cryopreservation equipment market provides a comprehensive analysis of the market dynamics, including detailed SWOT analysis. The market’s strengths lie in its advanced technological capabilities, with over 60% of the market dominated by high-precision, automated systems. Weaknesses include the complexity and high operational costs of cryogenic equipment, which limit adoption in smaller institutions.

Opportunities within the market include increased investment in stem cell research, particularly in emerging regions, where demand for cryopreservation equipment is growing at an accelerated pace. However, threats from regulatory challenges and high maintenance costs pose risks to steady market growth. As more than 45% of global research facilities invest in cryopreservation equipment, the market remains poised for robust growth.